About CardioAbstracts
HFSA’s Cardio Abstracts program delivers expert-led discussions on recently presented clinical trial data in a convenient, interactive format. This 45-minute live seminar features Q&A with leading clinicians, recordings, and downloadable resources available for on-demand learning. This program is designed to support diverse learning styles and provide practical insights for clinicians specializing in heart failure care.
Chronic kidney disease (CKD) impacts nearly 50% of individuals with heart failure, characterized by mildly reduced ejection fraction (HFmrEF) or heart failure with preserved ejection fraction (HFpEF). Patients with these conditions also often have other disorders, such as atrial fibrillation or type 2 diabetes mellitus, which can result in worse health outcomes than any of these conditions would produce individually. Join HFSA faculty as they review and answer questions about the recently presented clinical trial data and how HF and CKD may impact patient care.
Lifetime Benefits of Comprehensive Medical Therapy in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial
Moderator: Javed Butler, MD, MPH, MBA
President of the Baylor Scott and White Research Institute
Senior Vice President for the Baylor Scott and White Health
Distinguished Professor of Medicine at the University of Mississippi
Jackson, MS
Speaker: Jawad Haider Butt, MD, PhD
Department of Cardiology
Rigshospitalet
Copenhagen University Hospital
Copenhagen, Denmark
BHF Cardiovascular Research Centre
University of Glasgow
Glasgow, United Kingdom
Speaker: Kieran Docherty, BSc (MedSci), MBChB (Hons), MRCP
Clinical Senior Lecturer
University of Glasgow
Glasgow, United Kingdom
Speaker: Shingo Matsumoto, MD, PhD
Associate Professor
Division of Cardiovascular Medicine
Department of Internal Medicine
Toho University of Cardiovascular Medicine
Tokyo, Japan
Speaker: Shelley Zieroth, MD
Professor at the College of Medicine,
Max Rady Faculty of Health Sciences, University of Manitoba
Director of the Heart Failure and Heart Transplant Clinics
at St. Boniface Hospital
Winnipeg, Canada
Support for this program is provided by a grant from Bayer.
Cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
CardioAbstracts is a non-accredited educational program that utilizes an online format to provide timely information and the opportunity to interact with faculty and ask questions to find more information about recent clinical trial data in amyloidosis.